| Aktie | Ticker | Breite | GCS | 2026/Q1 | 2025/Q4 | 2025/Q3 | 2025/Q2 | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | ||||
| 932.897.070 $ | +100.833.840 $ | +140,7 % | 9 | 805.541.287 $ | +184.698.071 $ | +60,1 % | 6 | 601.685.750 $ | +236.571.653 $ | +85,0 % | 5 | 365.114.097 $ | -35.727.273 $ | +7,8 % | 5 | ||||
| Scholar Rock Holding Corp | SRRK | → 0 | Schwach | 339.088.572 $ | +35.247.001 $ | +11,6 % | 1 | 303.841.571 $ | +94.817.324 $ | +45,4 % | 1 | 209.024.247 $ | +10.215.471 $ | +5,1 % | 1 | 198.808.776 $ | +18.354.170 $ | +10,2 % | 1 |
| Mineralys Therapeutics, Inc. | MLYS | → 0 | Schwach | 159.045.878 $ | -54.013.365 $ | -25,4 % | 1 | 213.059.243 $ | -24.439.443 $ | -10,3 % | 1 | 237.498.686 $ | +160.717.073 $ | +209,3 % | 1 | 76.781.613 $ | -13.336.053 $ | -14,8 % | 1 |
| ALUMIS INC. | ALMS | → 0 | Neutral | 139.785.175 $ | +83.597.011 $ | +148,8 % | 1 | 56.188.164 $ | +37.030.698 $ | +193,3 % | 1 | ||||||||
| Kalaris Therapeutics, Inc. | KLRS | → 0 | Neutral | 74.710.427 $ | -34.571.377 $ | -31,6 % | 1 | 109.281.804 $ | +43.111.896 $ | +65,2 % | 1 | 66.169.908 $ | +35.603.532 $ | +116,5 % | 1 | 30.566.376 $ | -61.361.714 $ | -66,7 % | 1 |
| Septerna, Inc. | SEPN | → 0 | Neutral | 75.673.546 $ | -12.124.143 $ | -13,8 % | 1 | 87.797.689 $ | +28.562.591 $ | +48,2 % | 1 | 59.235.098 $ | +25.948.815 $ | +78,0 % | 1 | 33.286.283 $ | +15.052.832 $ | +82,6 % | 1 |
| SpyGlass Pharma, Inc. | SGP | → 0 | Stark | 54.668.882 $ | +54.668.882 $ | 1 | |||||||||||||
| Neurogene Inc. | NGNE | → 0 | Schwach | 34.617.280 $ | -755.536 $ | -2,1 % | 1 | 35.372.816 $ | +5.615.005 $ | +18,9 % | 1 | 29.757.811 $ | +4.086.762 $ | +15,9 % | 1 | 25.671.049 $ | +5.563.492 $ | +27,7 % | 1 |
| Inventiva S.A. | IVA | → 0 | Neutral | 28.831.168 $ | +4.675.325 $ | +19,4 % | 1 | ||||||||||||
| SUTRO BIOPHARMA, INC. | STRO | → 0 | Neutral | 26.476.142 $ | +24.110.042 $ | +1.019,0 % | 1 | ||||||||||||
| 932.897.070 $ | +100.833.840 $ | +140,7 % | 9 | 805.541.287 $ | +184.698.071 $ | +60,1 % | 6 | 601.685.750 $ | +236.571.653 $ | +85,0 % | 5 | 365.114.097 $ | -35.727.273 $ | +7,8 % | 5 | ||||